Depressive Störungen zählen zu den häufigsten Beratungsanlässen und Erkrankungen in der Versorgung. Der vorliegende Beitrag gibt einen Überblick über die wichtigsten psychotherapierelevanten Aspekte der aktuellen Revision der S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression, die im November 2015 veröffentlicht wurde.

Keywords:
Depression, Nationale Versorgungsleitlinie, Psychotherapie
1.
DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (eds) für die Leitliniengruppe Unipolare Depression: S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression - Langfassung, ed 2, Version 2. www. depression.versorgungsleitlinien.de, 2015; DOI: 10.6101/ AZQ/000266.
2.
Meyer B, Bierbrodt J, Schröder J, Berger T, Beevers CG, Weiss M, Jacob G, Späth C, Andersson G, Lutz W, Hautzinger M, Löwe B, Rose M, Hohagen F, Caspar F, Greiner W, Moritz S, Klein JP: Effects of an Internet intervention (Deprexis) on severe depressive symptoms: randomized controlled trial. Internet Interv 2015;2:48-59.
3.
Meyer B, Laux G, Bauer M, Hajak G, Niklewski G, Schlaepfer T, Schmauß M, Volz HP, Zwanzger P, Hautzinger M: Internetbasierte Interventionen in der Depressionsbehandlung: Zwischenbilanz zur Evidenz im deutschsprachigen Raum. 2016 (eingereicht).
© 2016 S. Karger GmbH, Freiburg
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.